This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: A Spotlight on Inventor Thomas Pfeifer
Introduction
Thomas Pfeifer, an innovative inventor based in Allschwil, Switzerland, has made significant contributions to the field of pharmaceutical science. With a focus on developing unique compounds, he has been a part of transformative research that addresses various medical needs.
Latest Patents
Thomas holds a patent for "1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives." This invention relates to novel compounds represented by a specific formula, which are expected to advance therapeutic applications and offer solutions in pharmacology.
Career Highlights
Currently, Thomas Pfeifer is affiliated with Actelion Pharmaceuticals Ltd., where he continues to engage in innovative research. His dedication to enhancing medical treatments through scientific discovery demonstrates his commitment to advancing the pharmaceutical industry.
Collaborations
Throughout his career, Thomas has collaborated with notable colleagues such as Heinz Fretz and Markus Gude. These partnerships have been instrumental in fostering a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
In summary, Thomas Pfeifer's innovative work and his patent for critical pharmaceutical compounds exemplify his role as a valuable contributor to modern science. His collaborations and ongoing efforts at Actelion Pharmaceuticals Ltd. highlight his impact on the future of drug development and therapeutic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile